Researchers from Dana-Farber Cancer Institute Report on Findings in Disease-Free Survival [Palbociclib With Adjuvant Endocrine Therapy In Early Breast Cancer (Pallas): Interim Analysis of a Multicentre, Open-label, Randomised, Phase 3 Study]

Source :: Women's Health Weekly. April 8, 2021, 5964
Publication Year :: 2021
Abstract: 2021 APR 8 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Fresh data on Epidemiology - Disease-Free Survival are presented in a new report. According [...]

Subjects :: Pfizer Inc. -- Reports
Women -- Health aspects
Oncology, Experimental -- Reports -- Health aspects -- Analysis
Cancer -- Adjuvant treatment -- Research
Clinical trials -- Reports -- Analysis -- Health aspects
Epidemiology -- Analysis -- Reports -- Health aspects
Breast cancer -- Care and treatment
Pharmaceutical industry -- Health aspects -- Analysis -- Reports
Health
Women's issues/gender studies

Tools